Article
Current progress of tacrolimus dosing in solid organ transplant recipients: Pharmacogenetic considerations.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Jun 2018
Zhang Xiao, Lin Guigao, Tan Liming, Li Jinming
Abstract excerpt
Tacrolimus is effective for the prevention of acute rejection, but is also highly toxic and has great intra- and inter-individual variability in transplant patients. Genetic variation and other factors influence the response of an individual to tacrolimus treatment. Therefore, even if therapeutic drug monitoring is universally applied, rejection and toxicity still occur. Although the appropriate action on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
